# Fabry: Renal Function During Long-term ERT by 51Cr-EDTA Clearance

> **NCT02969200** · — · COMPLETED · sponsor: **Ulla Feldt-Rasmussen** · enrollment: 52 (actual)

## Conditions studied

- Fabry Disease

## Interventions

- **DRUG:** Enzyme replacement therapy

## Key facts

- **NCT ID:** NCT02969200
- **Lead sponsor:** Ulla Feldt-Rasmussen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2016-09
- **Final completion:** 2016-12-09
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2018-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02969200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02969200, "Fabry: Renal Function During Long-term ERT by 51Cr-EDTA Clearance". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02969200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*